Anti-human leukocyte antigen DQ antibodies in renal transplantation: Are we underestimating the most frequent donor specific alloantibodies?

被引:11
作者
Carta, Paolo [1 ]
Di Maria, Lorenzo [1 ]
Caroti, Leonardo [1 ]
Buti, Elisa [1 ]
Antognoli, Giulia [1 ]
Minetti, Enrico Eugenio [1 ]
机构
[1] Careggi Univ Hosp, Nephrol Unit, I-50134 Florence, Italy
关键词
HLA-SPECIFIC ANTIBODIES; CLINICAL-RELEVANCE; KIDNEY-TRANSPLANTATION; MEDIATED REJECTION; PREDICTOR; IMPACT;
D O I
10.1016/j.trre.2015.04.003
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The role of anti-human leukocyte antigens DQ region (HLA-DQ) in transplantation is historically less studied than HLA-DR and HLA class I regions, but several studies are demonstrating that anti HLA-DQ antibodies are among the most frequent anti HLA antibodies that develop after transplantation and can have great influence on the developing of humoral rejection and graft loss. In this article we review the gene structure and nomenclature of the HLA-DQ region, the role of anti HIA-DQ antibodies after and before transplantation and briefly the associations of particular HIA-DQ alleles and other diseases. (C) 2015 Elsevier Inc. All rights reserved.
引用
收藏
页码:135 / 138
页数:4
相关论文
共 32 条
[21]  
Ozawa Miyuki, 2006, Clin Transpl, P265
[22]   Clinical relevance of human leukocyte antigen antibodies in kidney transplantation from deceased donors: The North Italy Transplant program approach [J].
Poli, Francesca ;
Cardillo, Massimo ;
Scalamogna, Mario .
HUMAN IMMUNOLOGY, 2009, 70 (08) :631-635
[23]   The environment and the origins of islet autoimmunity and Type 1 diabetes [J].
Regnell, S. Eringsmark ;
Lernmark, A. .
DIABETIC MEDICINE, 2013, 30 (02) :155-160
[24]   BENEFICIAL EFFECT OF HLA-DQ COMPATIBILITY ON THE SURVIVAL OF CADAVERIC RENAL-ALLOGRAFTS IN CYCLOSPORINE-TREATED RECIPIENTS [J].
SENGAR, DPS ;
COUTURE, RA ;
RAMAN, S ;
JINDAL, SL .
TRANSPLANTATION, 1990, 49 (05) :1007-1009
[25]   De Novo Donor HLA-Specific Antibodies after Heart Transplantation Are an Independent Predictor of Poor Patient Survival [J].
Smith, J. D. ;
Banner, N. R. ;
Hamour, I. M. ;
Ozawa, M. ;
Goh, A. ;
Robinson, D. ;
Terasaki, P. I. ;
Rose, M. L. .
AMERICAN JOURNAL OF TRANSPLANTATION, 2011, 11 (02) :312-319
[26]   Clinical Relevance of Pretransplant HLA Class II Donor-specific Antibodies in Renal Transplantation Patients with Negative T-cell Cytotoxicity Crossmatches [J].
Song, Eun Young ;
Lee, Yu-joo ;
Hyun, Jungwon ;
Kim, Yon Su ;
Ahn, Curie ;
Ha, Jongwon ;
Kim, Sang Joon ;
Park, Myoung Hee .
ANNALS OF LABORATORY MEDICINE, 2012, 32 (02) :139-144
[27]   Predicting kidney graft failure by HLA antibodies: a prospective trial [J].
Terasaki, PI ;
Ozawa, M .
AMERICAN JOURNAL OF TRANSPLANTATION, 2004, 4 (03) :438-443
[28]   Mechanisms and role of HLA and non-HLA alloantibodies [J].
Tinckam, Kathryn J. ;
Chandraker, Anil .
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2006, 1 (03) :404-414
[29]   Celiac disease: how complicated can it get? [J].
Tjon, Jennifer May-Ling ;
van Bergen, Jeroen ;
Koning, Frits .
IMMUNOGENETICS, 2010, 62 (10) :641-651
[30]   Early and Late Acute Antibody-Mediated Rejection Differ Immunologically and in Response to Proteasome Inhibition [J].
Walsh, R. Carlin ;
Brailey, Paul ;
Girnita, Alin ;
Alloway, Rita R. ;
Shields, Adele Rike ;
Wall, Garth E. ;
Sadaka, Basma H. ;
Cardi, Michael ;
Tevar, Amit ;
Govil, Amit ;
Mogilishetty, Gautham ;
Roy-Chaudhury, Prabir ;
Woodle, E. Steve .
TRANSPLANTATION, 2011, 91 (11) :1218-1226